Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

Locally Advanced ◽

Short Term ◽

Open Label ◽

Phase 3 ◽

Factorial Trial ◽

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30757-5 ◽

2019 ◽

Vol 20 (2) ◽

pp. 267-281 ◽

Cited By ~ 21

Author(s):

James W Denham ◽

David Joseph ◽

David S Lamb ◽

Nigel A Spry ◽

Gillian Duchesne ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Locally Advanced ◽

Short Term ◽

Phase 3 ◽

Factorial Trial ◽

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70423-0 ◽

2012 ◽

Vol 13 (12) ◽

pp. 1260-1270 ◽

Cited By ~ 43

Author(s):

James W Denham ◽

Chantelle Wilcox ◽

David Joseph ◽

Nigel A Spry ◽

David S Lamb ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Zoledronic Acid ◽

Locally Advanced ◽

Phase 3 ◽

Factorial Trial ◽

Secondary Endpoints

Faculty Opinions recommendation of Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.719895455.793514259 ◽

2016 ◽

Author(s):

Badrinath Konety

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation Therapy ◽

Locally Advanced ◽

Androgen Deprivation ◽

Phase 3 ◽

Locally Advanced Prostate Cancer

Paradoxical metastatic progression following 3months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2013.03.025 ◽

2013 ◽

Vol 107 (2) ◽

pp. 123-128 ◽

Cited By ~ 5

Author(s):

James W. Denham ◽

Allison Steigler ◽

Keen-Hun Tai ◽

David Joseph ◽

John Matthews ◽

...

Keyword(s):

Prostate Cancer ◽

Locally Advanced ◽

Metastatic Progression ◽

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?

European Urology Supplements ◽

10.1016/j.eursup.2010.10.004 ◽

2010 ◽

Vol 9 (11) ◽

pp. 788-793 ◽

Cited By ~ 3

Author(s):

Michel Bolla

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Current Status ◽

Androgen Suppression ◽

The Way

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer

Cancer ◽

10.1002/cncr.21989 ◽

2006 ◽

Vol 107 (2) ◽

pp. 389-395 ◽

Cited By ~ 60

Author(s):

Nicholas Bruchovsky ◽

Laurence Klotz ◽

Juanita Crook ◽

Shawn Malone ◽

Charles Ludgate ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Biochemical Recurrence ◽

Phase Ii Trial ◽

Locally Advanced ◽

Intermittent Androgen Suppression ◽

Prospective Phase ◽

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(11)70063-8 ◽

2011 ◽

Vol 12 (5) ◽

pp. 451-459 ◽

Cited By ~ 278

Author(s):

James W Denham ◽

Allison Steigler ◽

David S Lamb ◽

David Joseph ◽

Sandra Turner ◽

...

Keyword(s):

Prostate Cancer ◽

Randomised Trial ◽

Locally Advanced ◽

Androgen Deprivation ◽

Short Term ◽

Locally Advanced Prostate Cancer

Monte Carlo simulation of a Markov Model for a phase III clinical trial evaluating the addition of total androgen suppression (TAS) to radiation versus radiation alone for locally advanced prostate cancer (RTOG 86–10)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01028-9 ◽

2003 ◽

Vol 57 (2) ◽

pp. S215-S216 ◽

Cited By ~ 2

Author(s):

A.A Konski ◽

E Sherman ◽

M Krahn ◽

K Bremner ◽

J Beck ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Monte Carlo Simulation ◽

Monte Carlo ◽

Locally Advanced ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(05)70348-x ◽

2005 ◽

Vol 6 (11) ◽

pp. 841-850 ◽

Cited By ~ 284

Author(s):

James W Denham ◽

Allison Steigler ◽

David S Lamb ◽

David Joseph ◽

Hedy Mameghan ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Oncology ◽

Controlled Trial ◽

Locally Advanced ◽

Oncology Group ◽

Short Term ◽

Radiation Oncology Group ◽

Randomised Controlled

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

The Lancet ◽

10.1016/s0140-6736(02)09408-4 ◽

2002 ◽

Vol 360 (9327) ◽

pp. 103-108 ◽

Cited By ~ 1297

Author(s):

Michel Bolla ◽

Laurence Collette ◽

Léo Blank ◽

Padraig Warde ◽

Jean Bernard Dubois ◽

...

Keyword(s):

Prostate Cancer ◽

Randomised Trial ◽

Locally Advanced ◽

Phase Iii ◽

Long Term Results ◽

External Irradiation ◽